Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-29T03:05:53.397Z Has data issue: false hasContentIssue false
  • English
  • Français

Schizophrenia-Like Psychosis in Thyroid Crisis

Published online by Cambridge University Press:  29 January 2018

Steven Greer  and
Victor Parsons
Steven Greer
Affiliation:
King's College Hospital, London, S.E.5
Victor Parsons
Affiliation:
King's College Hospital, London, S.E.5
Get access Rights & Permissions [Opens in a new window]

Extract

Very few cases of thyrotoxic psychoses have been reported during the last twenty years. Recent authoritative reviews on the management of thyrotoxicosis and its complications (Ingbar, 1966; Trotter, 1967) scarcely mention psychotic reactions. It seems that such conditions have become increasingly rare since the advent of modern anti-thyroid treatment. The present report attempts to summarize what is known about these disorders, and describes the clinical features, treatment and subsequent course of a schizophrenia-like psychosis which developed during thyroid crisis.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 114 , Issue 516 , November 1968 , pp. 1357 - 1362
Copyright
Copyright © Royal College of Psychiatrists, 1968 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Basedow, C. A. (1840). “Exophthalmos durch Hypertrophie des Zellgewebes in der Augenhøhle.” Wschr. ges. Heilk., March 28, Cited by Major, R. H. (1959).Google Scholar
Bluestone, H. (1957). “Hyperthyroidism masquerading as functional psychosis.” Amer. Practnr. Dig. Treat., 8, 557–558.Google Scholar
Bradley, P. B. (1965). “Some aspects of drug action on brain stem mechanisms.” In: Proc. Leeds Symp. on Behavioural Disorders (ed. Jenner, ). Dagenham, Essex: May and Baker.Google Scholar
Bradley, P. B., Wolstencroft, J. H., Høsli, L., and Avanzino, G. L. (1966). “Neuronal basis for the central action of chlorpromazine.” Nature, 212, 1425–1427.Google Scholar
Bursten, B. (1961). “Psychoses associated with thyrotoxicosis.” Arch. gen. Psychiat., 4, 267–273.CrossRefGoogle Scholar
Connell, P. H. (1958). Amphetamine Psychosis. Maudsley Monogr. No. 5. London: Chapman & Hall.Google Scholar
Conrad, A. (1934). “The psychiatric study of hyperthyroid patients.” J. nerv. ment. Dis., 79, 505–529.Google Scholar
Cossa, P., and Sassi, P. (1938). “Les formes psychiques pures et prévalentes de l'hyperthyroïdie.” Presse méd., 46, 493–495.Google Scholar
Danowski, T. S., Heineman, A. C., Bonessi, J. V., and Moses, C. (1964). “Effects of thyroid hormone excesses on pressor activity and epinephrine responses.” Metabolism, 13, 747–752.Google Scholar
De Risio, C., and Murmann, W. (1967). “Anxiety and the pulse.” Brit. med. J., i, 373.Google Scholar
Dewhurst, W. G. (1965). “On the chemical basis of mood.” J. psychosom Res., 9, 115–127.Google Scholar
Dunlap, H. F., and Moersch, F. P. (1935). “Psychic manifestations associated with hyperthyroidism.” Amer. J. Psychiat., 91, 1215–1236.Google Scholar
Earll, J. M., and McDonald, H. B. (1965). “Severe thyrotoxicosis (thyroid crisis).” South West Med., 46, 373–375.Google Scholar
Ewen, J. H. (1932). “A case of psychosis with hyperthyroidism treated with ergotamine.” Lancet, i, 342.Google Scholar
Foss, H. L., and Jackson, J. A. (1924). “The relationship of goitre to mental disorders.” Amer. J. med. Sci., 167, 724–734.Google Scholar
Gaffney, T. E., Braunwald, E., and Kahler, R. L. (1961). “Effects of guanethidine on tri-iodothyronine-induced hyperthyroidism in man.” New Engl. J. Med., 265, 16–20.Google Scholar
Granville-Grossman, K. L., and Turner, P. (1966). “The effect of propranolol on anxiety.” Lancet, i, 788–790.Google Scholar
Graves, R. J. (1835). “Newly observed affection of the thyroid gland in females.” Lond. med. surg. J., 7, 516–517.Google Scholar
Gregory, I. (1956). “Mental disorder associated with thyroid dysfunction.” Canad. med. Ass. J., 75, 489–492.Google Scholar
Harrison, T. S., Siegel, J. H., Wilson, W. S., and Weber, W. J. (1967). “Adrenergic reactivity in hyperthyroidism.” Arch. Surg., 94, 396–402.Google Scholar
Hill, D. (1953). “Psychiatric disorders of epilepsy.” Med. Press, 229, 473–475.Google Scholar
Ingbar, S. H. (1966). “Thyrotoxic storm.” New Engl. J. Med., 274, 1252–1254.Google Scholar
Ingham, S. D., and Nielsen, J. M. (1931). “Thyroid psychosis: difficulties in diagnosis.” J. nerv. ment. Dis., 74, 271–277.CrossRefGoogle Scholar
Jamieson, G. R., and Wall, J. H. (1936). “Psychoses associated with hyperthyroidism.” Psychiat. Quart., 10, 464–480.Google Scholar
Johnson, W. O. (1928). “Psychosis and hyperthyroidism.” J. nerv. ment. Dis., 67, 558–566.CrossRefGoogle Scholar
Kety, S. S. (1966). “Catecholamines in neuropsychiatric states.” Pharmacol. Rev., 18, 787–798.Google Scholar
Kleinschmidt, H. J., Waxenberg, S. E., and Cuker, R. (1956). “Psychophysiology and psychiatric management of thyrotoxicosis: a two-year follow-up study.” J. Mt. Sinai Hosp., 23, 131–153.Google Scholar
Lahey, F. H. (1931). “Apathetic thyroidism.” Ann. Surg., 93, 1026–1036.CrossRefGoogle Scholar
Lancet (1967). Annotation: “Central action of chlorpromazine.” i, 553.Google Scholar
Levine, R. J., and Sjoerdsma, A. (1963). “Estimation of monoamine oxidase activity in man.” Ann. N.Y. Acad. Sci., 107, 966–974.Google Scholar
Lidz, T., and Whitehorn, J. C. (1949). “Psychiatric problems in a thyroid clinic.” J. Amer. med. Ass., 139, 698–701.Google Scholar
Locke, W. (1967). “Unusual manifestations of Grave's disease.” Med. Clin. N. Amer., 51, 915–924.CrossRefGoogle Scholar
McGee, R. R., Whittaker, R. J., and Tullis, I. F. (1959). “Apathetic thyroidism: review of the literature and report of four cases.” Ann. int. Med., 50, 1418–1432.Google Scholar
McGhie, A. (1967). “Studies of cognitive disorder in schizophrenia.” In: Recent Developments in Schizophrenia (eds. Coppen, and Walk, ). Ashford, Kent: The Royal Medico-Psychological Association.Google Scholar
Major, R. H. (1959). Classic Descriptions of Disease, 3rd edn., pp. 276–279 and 282–284. Illinois: Thomas.Google Scholar
Marley, E. (1966). “Behavioural and electrophysiological effects of catecholamines.” Pharmacol. Rev., 18, 753–768.Google Scholar
Marsden, C. D., Foley, T. H., Owen, D. A. L., and McAllister, R. G. (1967). “Peripheral beta-adrenergic receptors concerned with tremor.” Clin. Sci., 33, 53–65.Google Scholar
Martin, E. A. (1963). “Thyrotoxic confusional state.” Irish J. med. Sci., 448, 187–196.Google Scholar
Mayer-Gross, W., Slater, E., and Roth, M. (1960). Clinical Psychiatry, 2nd Ed. p. 327. London: Cassell.Google Scholar
Mittelman, B. (1933). “Psychogenic factors and psychotherapy in hyperthyreosis and rapid mental imbalance.” J. nerv. ment. Dis., 77, 465–484.Google Scholar
Murmann, W., Almirante, L., and Saccani-Guelfi, M. (1966). “Central nervous system effects of four beta-adrenergic receptor blocking agents.” J. Pharm. Pharmacol., 18, 317–318.Google Scholar
Packard, F. H. (1909). “An analysis of the psychosis associated with Grave's Disease.” Amer. J. Insan., 66, 189–202.Google Scholar
Parry, C. H. (1825). Collections from the Unpublished Medical Writings, Underwoods, London, vol. II, pp. 111–120, Cited by Major, R. H. (1959).Google Scholar
Parsons, V., and Jewitt, D. E. (1967). “The effects of adrenergic blockade in thyrotoxic crisis and arrhythmias.” Postgrad. med. J., 43, 756–762.Google Scholar
Pond, D. A. (1957). “Psychiatric aspects of epilepsy.” J. Ind. med. Prof., 3, 1441.Google Scholar
Reisner, H. (1963). “Melancholie und Morbus Basedow.” Schweiz. Arch. Neurol. Psychiat., 91, 233–238.Google Scholar
Rowlands, D. J., Howitt, G., and Markman, P. (1965). “Propranolol (Inderal) in disturbances of cardiac rhythm.” Brit. med. J., i, 891–894.CrossRefGoogle Scholar
Rulison, E. T., White, J. D., and Stalker, L. K. (1941). “Mental disorder associated with hyperthyroidism.” Amer. J. Surg., 54, 499–501.CrossRefGoogle Scholar
Sattler, H. (1909). Die Basedowsche Krankheit. Leipzig: Engelman.Google Scholar
Scheibel, M. E., and Scheibel, A. B. (1962). “Hallucinations and the brain stem: Reticular core.” In: Hallucinations (ed. West, ). New York: Grune and Stratton.Google Scholar
Slater, E., Beard, A. W., and Glithero, E. (1963). “The schizophrenia-like psychoses of epilepsy.” Brit. J. Psychiat., 109, 95–150.Google Scholar
Staehelin, B. (1964). “Psychosomatische Aspekte bei Hyperthyreose.” Schweiz. med. Wschr., 94, 1054–1059.Google Scholar
Trotter, W. R. (1967). “The treatment of thyrotoxicosis.” Hosp. Med., 1, 680–690.Google Scholar
Turner, P., Granville-Grossman, K. L., and Smart, J. V. (1965). “Effect of adrenergic receptor blockade on the tachycardia of thyrotoxicosis and anxiety state.” Lancet, ii, 1316–1318.CrossRefGoogle Scholar
Vaughan Williams, E. M. (1967). “Central nervous system effects of beta-adrenergic blocking drugs.” Ann. N.Y. Acad. Sci., 139, 808–814.Google Scholar
Voloshin, I. A. M., and Ermulovich, I. A. V. (1965). “K voprosu o taktike pri tireoidnom psikhoze.” Sovet. Med., 28, 118–121.Google Scholar
Wahlberg, P., and Lamberg, B. A. (1963). “Iodine metabolism in a case of thyrotoxic crisis.” J. clin. Endocr., 23, 397–400.CrossRefGoogle Scholar
Weaver, J. A., Jones, A., and Smith, R. A. (1956). “Thyrotoxic coma (apathetic crisis).” Brit. med. J., i, 20–23.Google Scholar
Welti, H., Baruk, H., and Mathey, Y. (1938). “Diagnostic des troubles psychiques Basedowiens et des faux syndromes mentaux d'apparence thyroidienne.” Presse méd., 46, 1036–1038.Google Scholar
Wiswell, J. G., Hurwitz, G. E., Coronho, V., Bing, O. H. L., and Child, D. L. (1963). “Urinary catecholamines and their metabolites in hyperthyroidism and hypothyroidism.” J. clin. Endocrinol., 23, 1102–1106.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.